According to Endo International 's latest financial reports the company's current earnings (TTM) are -$2.4 B. In 2022 the company made an earning of -$2.89 B a decrease over its 2021 earnings that were of -$0.55 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$2.4 B | -17.18% |
2022 | -$2.89 B | 428.37% |
2021 | -$0.55 B | 1961.25% |
2020 | -$26.52 M | -92.31% |
2019 | -$0.35 B | -63.26% |
2018 | -$0.94 B | -36.69% |
2017 | -$1.49 B | -62.21% |
2016 | -$3.93 B | 172.89% |
2015 | -$1.44 B | 4670.78% |
2014 | -$30.14 M | -94.48% |
2013 | -$0.55 B | -26.35% |
2012 | -$0.75 B | -310.86% |
2011 | $0.35 B | -16.4% |
2010 | $0.42 B | 16.97% |
2009 | $0.35 B | -9.08% |
2008 | $0.39 B | 11.98% |
2007 | $0.35 B | 51.13% |
2006 | $0.23 B | -27.91% |
2005 | $0.32 B | 40.31% |
2004 | $0.23 B | 112.02% |
2003 | $0.10 B | 79% |
2002 | $60.89 M | -256.7% |
2001 | -$38.86 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Zogenix ZGNX | -$0.22 B | -91.14% | ๐บ๐ธ USA |
Cara Therapeutics
CARA | -$0.12 B | -95.07% | ๐บ๐ธ USA |